Browsing by Author Maione, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2007ACE-inibizione, antagonismo recettoriale e terapia combinata in soggetti microalbuminurici con fattori di rischio cardiovascolare. Protocollo dello studio randomizzato multicentrico LIRICO (Long-term Impact of RAS Inhibition on Cardiorenal Outcomes)Craig, Jonathan; Strippoli, Giovanni; Gesualdo, L; Maione, A; Moschetta, A; Nicolucci, A; Palasciano, G; Pellegrini, F; Procaccini, D A; Pugliese, G; Tognoni, G; School of Public Health: Public Health; School of Public Health: Public HealthACE-inibizione, antagonismo recettoriale e terapia combinata in soggetti microalbuminurici con fattori di rischio cardiovascolare. Protocollo dello studio randomizzato multicentrico LIRICO (Long-term Impact of RAS Inhibition on Cardiorenal Outcomes), Giornale Italiano di Nefrologia (GIN), vol.24,(5),2007,pp 446-456
2011Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trialsCraig, Jonathan; Perkovic, Vlado; Strippoli, Giovanni; De Cosmo, Salvatore; et al, Various; Gao, Peggy; Graziano, Giusi; Johnson, David; Maione, A; Mann, Johannes; Mitchell, Ruth; Navaneethan, Sankar D.; Nicolucci, Antonio; Tognoni, Gianni; School of Public Health: Public Health; The George Institute for Global Health; School of Public Health: Public HealthAngiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials, Nephrology, Dialysis, Transplantation, vol.26, 9, 2011,pp 2827-2847
2010Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocolCraig, Jonathan; Strippoli, Giovanni; et al, various; Maione, A; Navaneethan, Sankar D.; Nicolucci, A; Palmer, Suetonia; Pellegrini, F; Procaccini, D A; Saglimbene, Valeria; Santoro, Antonio Scioscia; Triolo, Giorgio; Vecchio, Mariacristina; School of Public Health: Public Health; Western Clinical School: Medicine (Westmead)Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol, Trials, vol.11, N/A,pp 70-N/A